brexpiprazole   Click here for help

GtoPdb Ligand ID: 7672

Synonyms: OPC 34712 | OPC-34712 | Rxulti®
Approved drug
brexpiprazole is an approved drug (FDA (2015), EMA (2018))
Compound class: Synthetic organic
Comment: Brexpiprazole is a serotonin-dopamine activity modulator (SDAM) [2].
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: brexpiprazole

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 76.81
Molecular weight 433.18
XLogP 5.36
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2
Isomeric SMILES O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2
InChI InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)
InChI Key ZKIAIYBUSXZPLP-UHFFFAOYSA-N
References
1. Citrome L. (2015)
Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?.
Int J Clin Pract, 69 (9): 978-97. [PMID:26250067]
2. Maeda K, Sugino H, Akazawa H, Amada N, Shimada J, Futamura T, Yamashita H, Ito N, McQuade RD, Mørk A et al.. (2014)
Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
J Pharmacol Exp Ther, 350 (3): 589-604. [PMID:24947465]